These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

342 related items for PubMed ID: 31152264

  • 1. Distribution of carbapenem resistance mechanisms in clinical isolates of XDR Pseudomonas aeruginosa.
    De Rosa A, Mutters NT, Mastroianni CM, Kaiser SJ, Günther F.
    Eur J Clin Microbiol Infect Dis; 2019 Aug; 38(8):1547-1552. PubMed ID: 31152264
    [Abstract] [Full Text] [Related]

  • 2. Characterization of clinical extensively drug-resistant Pseudomonas aeruginosa in the Hunan province of China.
    Li J, Zou M, Dou Q, Hu Y, Wang H, Yan Q, Liu WE.
    Ann Clin Microbiol Antimicrob; 2016 May 23; 15(1):35. PubMed ID: 27215335
    [Abstract] [Full Text] [Related]

  • 3. [Carbapenem resistance in Pseudomonas aeruginosa isolates: an example of interaction between different mechanisms].
    Santella G, Pollini S, Docquier JD, Almuzara M, Gutkind G, Rossolini GM, Radice M.
    Rev Panam Salud Publica; 2011 Dec 23; 30(6):545-8. PubMed ID: 22358400
    [Abstract] [Full Text] [Related]

  • 4. Interplay between mutational and horizontally acquired resistance mechanisms and its association with carbapenem resistance amongst extensively drug-resistant Pseudomonas aeruginosa (XDR-PA).
    Shu JC, Chia JH, Siu LK, Kuo AJ, Huang SH, Su LH, Wu TL.
    Int J Antimicrob Agents; 2012 Mar 23; 39(3):217-22. PubMed ID: 22079532
    [Abstract] [Full Text] [Related]

  • 5. Mutational inactivation of OprD in carbapenem-resistant Pseudomonas aeruginosa isolates from Korean hospitals.
    Kim CH, Kang HY, Kim BR, Jeon H, Lee YC, Lee SH, Lee JC.
    J Microbiol; 2016 Jan 23; 54(1):44-49. PubMed ID: 26727901
    [Abstract] [Full Text] [Related]

  • 6. OprD mutations and inactivation, expression of efflux pumps and AmpC, and metallo-β-lactamases in carbapenem-resistant Pseudomonas aeruginosa isolates from South Korea.
    Lee JY, Ko KS.
    Int J Antimicrob Agents; 2012 Aug 23; 40(2):168-72. PubMed ID: 22633564
    [Abstract] [Full Text] [Related]

  • 7. In vitro antibacterial activity of rifampicin in combination with imipenem, meropenem and doripenem against multidrug-resistant clinical isolates of Pseudomonas aeruginosa.
    Hu YF, Liu CP, Wang NY, Shih SC.
    BMC Infect Dis; 2016 Aug 24; 16(1):444. PubMed ID: 27553962
    [Abstract] [Full Text] [Related]

  • 8. [The roles of active efflux system overexpression and outer membrane protein OprD deficiency or loss in carbapenem resistance of Pseudomonas aeruginosa].
    Yi MY, Wang PY, Huang HJ, Liu YC.
    Zhonghua Yi Xue Za Zhi; 2006 Feb 21; 86(7):457-62. PubMed ID: 16677571
    [Abstract] [Full Text] [Related]

  • 9. Pseudomonas aeruginosa carbapenem resistance mechanisms in Spain: impact on the activity of imipenem, meropenem and doripenem.
    Riera E, Cabot G, Mulet X, García-Castillo M, del Campo R, Juan C, Cantón R, Oliver A.
    J Antimicrob Chemother; 2011 Sep 21; 66(9):2022-7. PubMed ID: 21653605
    [Abstract] [Full Text] [Related]

  • 10. Emergence of Imipenem-Resistant Pseudomonas aeruginosa Clinical Isolates from Egypt Coharboring VIM and IMP Carbapenemases.
    El-Domany RA, Emara M, El-Magd MA, Moustafa WH, Abdeltwab NM.
    Microb Drug Resist; 2017 Sep 21; 23(6):682-686. PubMed ID: 28085553
    [Abstract] [Full Text] [Related]

  • 11. Carbapenem resistance mechanisms in Pseudomonas aeruginosa: alterations of porin OprD and efflux proteins do not fully explain resistance patterns observed in clinical isolates.
    El Amin N, Giske CG, Jalal S, Keijser B, Kronvall G, Wretlind B.
    APMIS; 2005 Mar 21; 113(3):187-96. PubMed ID: 15799762
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of Carbapenem Resistance Mechanisms and Its Association with Pseudomonas aeruginosa Infections in the Northwest of Iran.
    Akhi MT, Khalili Y, Ghotaslou R, Yousefi S, Kafil HS, Naghili B, Sheikhalizadeh V.
    Microb Drug Resist; 2018 Mar 21; 24(2):126-135. PubMed ID: 28654368
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Characterization and genetic analysis of extensively drug-resistant hospital acquired Pseudomonas aeruginosa isolates.
    Abdelaziz MA, El-Aziz AMA, El-Sokkary MMA, Barwa R.
    BMC Microbiol; 2024 Jun 26; 24(1):225. PubMed ID: 38926687
    [Abstract] [Full Text] [Related]

  • 15. Overexpression of MexAB-OprM efflux pump in carbapenem-resistant Pseudomonas aeruginosa.
    Pan YP, Xu YH, Wang ZX, Fang YP, Shen JL.
    Arch Microbiol; 2016 Aug 26; 198(6):565-71. PubMed ID: 27060003
    [Abstract] [Full Text] [Related]

  • 16. Reduced production of OprM may promote oprD mutations and lead to imipenem resistance in Pseudomonas aeruginosa carrying an oprD-group 1A allele.
    Shu JC, Su LH, Chiu CH, Kuo AJ, Liu TP, Lee MH, Su IN, Wu TL.
    Microb Drug Resist; 2015 Apr 26; 21(2):149-57. PubMed ID: 25386722
    [Abstract] [Full Text] [Related]

  • 17. A highly carbapenem-resistant Pseudomonas aeruginosa isolate with a novel blaVIM-4/blaP1b integron overexpresses two efflux pumps and lacks OprD.
    Maniati M, Ikonomidis A, Mantzana P, Daponte A, Maniatis AN, Pournaras S.
    J Antimicrob Chemother; 2007 Jul 26; 60(1):132-5. PubMed ID: 17483142
    [Abstract] [Full Text] [Related]

  • 18. Occurrence of intI1-associated VIM-5 carbapenemase and co-existence of all four classes of β-lactamase in carbapenem-resistant clinical Pseudomonas aeruginosa DMC-27b.
    Jahan MI, Rahaman MM, Hossain MA, Sultana M.
    J Antimicrob Chemother; 2020 Jan 01; 75(1):86-91. PubMed ID: 31647552
    [Abstract] [Full Text] [Related]

  • 19. Epidemiological, Physiological, and Molecular Characteristics of a Brazilian Collection of Carbapenem-Resistant Acinetobacter baumannii and Pseudomonas aeruginosa.
    Dias VC, Resende JA, Bastos AN, De Andrade Bastos LQ, De Andrade Bastos VQ, Bastos RV, Diniz CG, Da Silva VL.
    Microb Drug Resist; 2017 Oct 01; 23(7):852-863. PubMed ID: 28437232
    [Abstract] [Full Text] [Related]

  • 20. Molecular epidemiology of carbapenem-resistant Pseudomonas aeruginosa in an endemic area: comparison with global data.
    Karampatakis T, Antachopoulos C, Tsakris A, Roilides E.
    Eur J Clin Microbiol Infect Dis; 2018 Jul 01; 37(7):1211-1220. PubMed ID: 29644540
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.